Sector: Pharmaceuticals & Biotechnology

Small Cap

Accretion Nutraveda Share Price

ANL

₹259.30

0.00(0.00%)

9th Jul 2026 | 2:45 PM

NSE :

Open Free Demat Account

Accretion Nutraveda Performance

Price Movement

N/A

₹0.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹0.00

Low₹0.00

Open at₹0.00

Prev Close₹259.30

Volumes0

Avg Price₹0.00

Lower Circuit₹246.35

Upper Circuit₹272.25

Historical Performance

3M High₹300.00

3M Low₹197.05

1 Yr High₹300.00

1 Yr Low₹150.10

3 Yr High₹300.00

3 Yr Low₹150.10

5 Yr High₹300.00

5 Yr Low₹150.10

Summary

As of 10-07-2026 22:19, Accretion Nutraveda Ltd. share price today is ₹0, with a change of ₹-259.30 (-100.00%) from the previous close of ₹259.3. The stock opened at ₹0 and traded between ₹0 and ₹0, with a total traded volume of 0 shares. The company has a market capitalization of ₹187.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹300 and ₹150.1, respectively.

Accretion Nutraveda Ltd. valuation metrics include a P/E ratio of 37, and book value of ₹5.30. Profitability indicators show ROE of 14.28%.

Accretion Nutraveda Ltd. technical indicators include Day RSI at 51.74, Day MFI at 65.09, Day ADX at 16.39. Additional indicators include Commodity Channel Index (CCI) at -52.1 and Williams %R at -50.8. Momentum indicators show Day MACD at 2.18, Day MACD Signal Line at 4.39, DayATR at 10.76. Rate of Change indicators for Accretion Nutraveda Ltd. include ROC21 at 2.86.

Exponential moving averages include EMA5 at ₹256.7, EMA10 at ₹258, EMA12 at ₹258.4, EMA20 at ₹258, EMA26 at ₹256.2, EMA50 at ₹242.8. Simple moving averages include SMA5 at ₹256.1, SMA10 at ₹259.6, SMA20 at ₹260, SMA30 at ₹263, SMA50 at ₹245.1.

Support levels for Accretion Nutraveda are placed at First Support ₹253.77, Second Support ₹248.23, Third Support ₹245.47. Resistance levels are seen at First Resistance ₹262.07, Second Resistance ₹264.83, Third Resistance ₹270.37. Accretion Nutraveda Ltd. shareholding pattern shows promoter holding at 73.48%, FII holding at 1.08%, DII holding at 0%, public holding at 18.43%.

Accretion Nutraveda Fundamentals

Market Cap

Below industry Median

187.70 Cr.

PE Ratio (TTM)

Above industry Median

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

71% decr over last year

14.28

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Above industry Median

5.30

MFI

MFI is mid-range

65.09

RSI

RSI is mid-range

51.74

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

5.30

Accretion Nutraveda Financials

Data not available for chart

Indicator
No Record Found

Accretion Nutraveda Technicals

Accretion Nutraveda Ltd. EMA & SMA

₹259.30

12.25 (4.96%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹256.7

Day EMA10 ₹258

Day EMA12 ₹258.4

Day EMA20 ₹258

Day EMA26 ₹256.2

Day EMA50 ₹242.8

Accretion Nutraveda Support and Resistance

Resistance

First Resistance₹262.07

Second Resistance₹264.83

Third Resistance₹270.37

Support

First Support₹253.77

Second Support₹248.23

Third Support₹245.47

Technical Indicators

Day RSI51.74

Day MFI65.09

Day ADX16.39

Day Commodity Channel Index-52.10

William-50.80

Day MACD2.18

Day MACD Signal Line4.39

Day ATR10.76

Day ROC125-

Day ROC212.86

Accretion Nutraveda Shareholding Pattern

Held By	Mar 2026
Promoter	73.5
FII	1.1
DII	7
Public	18.4

Accretion Nutraveda Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	12 K	12 K	100.00%
Week	5.4 K	5.4 K	100.00%
1 Month	9.31 K	9.31 K	100.00%
6 Month	17.41 K	18.63 K	93.43%

Accretion Nutraveda SWOT Analysis

Strengths8

Weakness7

Opportunity0

Threats0

Annual Profit Growth higher than Sector Profit Growth

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Accretion Nutraveda Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Accretion Nutraveda Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹41	₹587.60	₹183.50	₹35	₹5.40
% Change	0.00%	-1.43%	-0.27%	-2.78%	-0.18%
Revenue TTM (₹ Cr)	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	₹-0.25	₹-34.95
PE TTM	9.60	-	12.40	-85.20	-1.30
1 Year Return		52.07		700	441
ROCE	-	3.56	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 224.00

+1.93%

AMANTA

Amanta Healthcare Ltd.

₹ 179.17

-2.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.60

+0.84%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 95.00

-1.04%

APL

Asston Pharmaceuticals Ltd.

₹ 76.50

+1.32%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.00

-0.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 282.55

+1.99%

AMWILL

Amwill Health Care Ltd.

₹ 41.00

-3.91%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-0.26%

SHELTER

Shelter Pharma Ltd.

₹ 27.40

+6.41%

TLL

Trident Lifeline Ltd.

₹ 262.50

-0.61%

DPL

Dipna Pharmachem Ltd.

₹ 5.76

-8.86%

ACHYUT

Achyut Healthcare Ltd.

₹ 8.20

+0.12%

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 38.55

-4.98%

CHCL

Cian Healthcare Ltd.

₹ 8.67

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.41

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1402.00

-0.61%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

SGRL

Shree Ganesh Remedies Ltd.

₹ 687.00

+1.43%

FAQ's on ANL

What is the Market Capitalization of Accretion Nutraveda Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 July 2026, the market cap for Accretion Nutraveda Ltd. is approximately ₹ 187.7 Cr.

What are the PE and PB ratios for Accretion Nutraveda Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Accretion Nutraveda Ltd. is 37, and the Price-to-Book (PB) ratio is 5.3.

What is the 52-Week High and Low for Accretion Nutraveda Ltd.?

Over the past 52 weeks, the highest price reached by Accretion Nutraveda Ltd. shares was ₹ 300, and the lowest price was ₹ 150.1.

Who are the major shareholders of Accretion Nutraveda Ltd.?

Significant shareholdings in Accretion Nutraveda Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Accretion Nutraveda Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Accretion Nutraveda Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy